You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0502 Serum matrix metalloproteinase-3 levels indicate c-reactive protein as one of boolean remission core measure sets in patients with rheumatoid arthritis by using anti-TNFα treatment

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Rheumatoid arthritis – anti-TNF therapy
AB0502 Serum matrix metalloproteinase-3 levels indicate c-reactive protein as one of boolean remission core measure sets in patients with rheumatoid arthritis by using anti-TNFα treatment

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hattori Y, Kaneko A, Kojima T, et al
AB0502 Serum matrix metalloproteinase-3 levels indicate c-reactive protein as one of boolean remission core measure sets in patients with rheumatoid arthritis by using anti-TNFα treatment
Annals of the Rheumatic Diseases 2013;71:666.